Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Blogs Landing Page

Blogs

Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024

Kendall Logan, MPH; Anne DiSalvo, MPH, MBA; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Kendall Logan, MPH; Anne DiSalvo, MPH...
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024

Theresa Schmidt, MA; Danny Bellet, MBA; Donna Dugan, PhD, MS; Erik Muther; David Sloan, PhD; Tom Valuck, MD, JD

Theresa Schmidt, MA; Danny Bellet, MB...
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023

David Blaisdell; Blog Editor: Tom Valuck, MD, JD

David Blaisdell; Blog Editor: Tom Val...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023

Jacqlyn Riposo, MBA; Tom Valuck, MD, JD

Jacqlyn Riposo, MBA; Tom Valuck, MD, ...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023

David Blaisdell; Sarena Ho, MSPH; Tom Valuck, MD, JD

David Blaisdell; Sarena Ho, MSPH; Tom...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022

Nina Regenold, MSc; Kaitlyn Esselman, MHS; David Blaisdell; Eva Lenoir, MPH; and Tom Valuck, MD, JD

Nina Regenold, MSc; Kaitlyn Esselman,...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways
Jan Ileto, MSPH
Quality Outlook
Turning Down the Heat: Measuring the Effects of Climate Change to Improve Health Equity
04/26/2022

Jan Ileto, MSPH, Jacqlyn Riposo, MBA, Alexis Malfesi, MSHS; Blog Editor: Tom Valuck, MD, JD 

Jan Ileto, MSPH, Jacqlyn Riposo, MBA,...
This blog explores the intersection between climate change and health equity, discussing opportunities to leverage quality measurement and value-based payment incentives to drive climate action and mitigate impacts on health equity.
This blog explores the intersection between climate change and health equity, discussing opportunities to leverage quality measurement and value-based payment incentives to drive climate action and mitigate impacts on health equity.
This blog explores the...
04/26/2022
Journal of Clinical Pathways
Rachael Peroutky, MSPH
Quality Outlook
Nurses are Burned Out. Can Quality Measures Help?
04/11/2022

Rachael Peroutky, MSPH, Tess Donckels, MSPH, Sarena Ho, Katie Schultz, Sara Khan Shirsekar; Blog Editor: Tom Valuck, MD, JD 

Rachael Peroutky, MSPH, Tess Donckels...
This blog addresses "nurse burnout," the occupational phenomena that many nurses face, and suggests that quality measurement strategies for nurse burnout may be most effective in the hospital setting since evidence tying burnout to patient...
This blog addresses "nurse burnout," the occupational phenomena that many nurses face, and suggests that quality measurement strategies for nurse burnout may be most effective in the hospital setting since evidence tying burnout to patient...
This blog addresses "nurse...
04/11/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways

Editor Insights

A Multistakeholder Look at Today’s New Reality
Editor Insights
A Multistakeholder Look at Today’s New Reality
05/22/2020

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, examines the shift in the health care industry from the viewpoint of providers, patients, and payers since the outbreak of the COVID-19 pandemic, calling stakeholders to use this reality check to better the health care...
Winston Wong, PharmD, examines the shift in the health care industry from the viewpoint of providers, patients, and payers since the outbreak of the COVID-19 pandemic, calling stakeholders to use this reality check to better the health care...
Winston Wong, PharmD, examines...
05/22/2020
Journal of Clinical Pathways
Editor Insights
Intelligent Scanning, Lack of Interoperability as Barriers to Quality Measures
02/12/2020

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, contends that CMMI needs to reexamine their current surrogate and direct measures of quality with the goal that, in the future, interoperability and expanded datasets will allow true measurement of quality of care.
Winston Wong, PharmD, contends that CMMI needs to reexamine their current surrogate and direct measures of quality with the goal that, in the future, interoperability and expanded datasets will allow true measurement of quality of care.
Winston Wong, PharmD, contends...
02/12/2020
Journal of Clinical Pathways
Editor Insights
Are We Really Measuring Quality?
12/03/2019

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, asserts that, rather than trying to develop, revise, and modify quality measures that are driven by innovation, we may be able to simplify the monitoring process with the development of high-level quality measures that...
Winston Wong, PharmD, asserts that, rather than trying to develop, revise, and modify quality measures that are driven by innovation, we may be able to simplify the monitoring process with the development of high-level quality measures that...
Winston Wong, PharmD, asserts...
12/03/2019
Journal of Clinical Pathways
Editor Insights
What is the Most Appropriate First-Line Treatment in CLL?
09/24/2019

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, reviews the current treatment options for CLL and argues that until real-world evidence trials occur, it is difficult to determine whether meaningful improvement has occurred in clinical outcomes and quality of life as a...
Winston Wong, PharmD, reviews the current treatment options for CLL and argues that until real-world evidence trials occur, it is difficult to determine whether meaningful improvement has occurred in clinical outcomes and quality of life as a...
Winston Wong, PharmD, reviews...
09/24/2019
Journal of Clinical Pathways
Editor Insights
Should ICER Look at Transformative Therapies?
09/12/2019

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, argues that under the current ICER value assessment framework and QALY measurements, there may never be a transformative therapy that demonstrates cost-effectiveness.
Winston Wong, PharmD, argues that under the current ICER value assessment framework and QALY measurements, there may never be a transformative therapy that demonstrates cost-effectiveness.
Winston Wong, PharmD, argues...
09/12/2019
Journal of Clinical Pathways
Editor Insights
Biosimilars in Oncology: ASCO's Position Statement and the Anticipated Cost-Savings
09/12/2018

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, breaks down the ASCO position statement on the utilization of biosimilars in oncology and ways in which the anticipated cost-savings may be achieved.
Winston Wong, PharmD, breaks down the ASCO position statement on the utilization of biosimilars in oncology and ways in which the anticipated cost-savings may be achieved.
Winston Wong, PharmD, breaks...
09/12/2018
Journal of Clinical Pathways
Editor Insights
Next-Generation Clinical Pathways
07/20/2018

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, highlights the relevance of personalized medicine in oncology care and outlines his views on what the "next-generation clinical pathway" should look like.
Winston Wong, PharmD, highlights the relevance of personalized medicine in oncology care and outlines his views on what the "next-generation clinical pathway" should look like.
Winston Wong, PharmD, highlights...
07/20/2018
Journal of Clinical Pathways
Editor Insights
Value-Based Oncology Care: It's All in the Eye of the Beholder
06/07/2018

Winston Wong, PharmD

Winston Wong, PharmD
As with so many other key words in health care today, there is no standard definition of what “value-based oncology care” entails; it is subject to different interpretations from payers, providers, and patients, according to Winston Wong,...
As with so many other key words in health care today, there is no standard definition of what “value-based oncology care” entails; it is subject to different interpretations from payers, providers, and patients, according to Winston Wong,...
As with so many other key words...
06/07/2018
Journal of Clinical Pathways
Editor Insights
CAR-T Reimbursement Levels Set by CMS, So Where Should Patients Be Treated?
04/19/2018

Winston Wong, PharmD

Winston Wong, PharmD
Will payers push for services to be provided on an outpatient basis, thus placing financial burden upon the patient, or will they allow the oncologist or facility to use their discretion as to where the infusion will take place?
Will payers push for services to be provided on an outpatient basis, thus placing financial burden upon the patient, or will they allow the oncologist or facility to use their discretion as to where the infusion will take place?
Will payers push for services to...
04/19/2018
Journal of Clinical Pathways
Editor Insights
Clinical Pathways: Are They Enough to Improve Cancer Care?
03/05/2018

Winston Wong, PharmD

Winston Wong, PharmD
Clinical pathways may require a deeper consideration of the patient experience in order to achieve the goals of the Triple Aim, according to Winston Wong, PharmD.
Clinical pathways may require a deeper consideration of the patient experience in order to achieve the goals of the Triple Aim, according to Winston Wong, PharmD.
Clinical pathways may require a...
03/05/2018
Journal of Clinical Pathways
Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024

Winston Wong, PharmD

Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Winston Wong
Editor Insights
A Look Back at Clinical Pathways in 2022
02/21/2023
Winston Wong, PharmD, Editor-in-Chief
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal...
02/21/2023
Journal of Clinical Pathways
A Multistakeholder Look at Today’s New Reality
Editor Insights
A Multistakeholder Look at Today’s New Reality
05/22/2020

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, examines the shift in the health care industry from the viewpoint of providers, patients, and payers since the outbreak of the COVID-19 pandemic, calling stakeholders to use this reality check to better the health care...
Winston Wong, PharmD, examines the shift in the health care industry from the viewpoint of providers, patients, and payers since the outbreak of the COVID-19 pandemic, calling stakeholders to use this reality check to better the health care...
Winston Wong, PharmD, examines...
05/22/2020
Journal of Clinical Pathways
Editor Insights
Intelligent Scanning, Lack of Interoperability as Barriers to Quality Measures
02/12/2020

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, contends that CMMI needs to reexamine their current surrogate and direct measures of quality with the goal that, in the future, interoperability and expanded datasets will allow true measurement of quality of care.
Winston Wong, PharmD, contends that CMMI needs to reexamine their current surrogate and direct measures of quality with the goal that, in the future, interoperability and expanded datasets will allow true measurement of quality of care.
Winston Wong, PharmD, contends...
02/12/2020
Journal of Clinical Pathways
Editor Insights
Are We Really Measuring Quality?
12/03/2019

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, asserts that, rather than trying to develop, revise, and modify quality measures that are driven by innovation, we may be able to simplify the monitoring process with the development of high-level quality measures that...
Winston Wong, PharmD, asserts that, rather than trying to develop, revise, and modify quality measures that are driven by innovation, we may be able to simplify the monitoring process with the development of high-level quality measures that...
Winston Wong, PharmD, asserts...
12/03/2019
Journal of Clinical Pathways
Editor Insights
What is the Most Appropriate First-Line Treatment in CLL?
09/24/2019

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, reviews the current treatment options for CLL and argues that until real-world evidence trials occur, it is difficult to determine whether meaningful improvement has occurred in clinical outcomes and quality of life as a...
Winston Wong, PharmD, reviews the current treatment options for CLL and argues that until real-world evidence trials occur, it is difficult to determine whether meaningful improvement has occurred in clinical outcomes and quality of life as a...
Winston Wong, PharmD, reviews...
09/24/2019
Journal of Clinical Pathways
Editor Insights
Should ICER Look at Transformative Therapies?
09/12/2019

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, argues that under the current ICER value assessment framework and QALY measurements, there may never be a transformative therapy that demonstrates cost-effectiveness.
Winston Wong, PharmD, argues that under the current ICER value assessment framework and QALY measurements, there may never be a transformative therapy that demonstrates cost-effectiveness.
Winston Wong, PharmD, argues...
09/12/2019
Journal of Clinical Pathways
Editor Insights
Biosimilars in Oncology: ASCO's Position Statement and the Anticipated Cost-Savings
09/12/2018

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, breaks down the ASCO position statement on the utilization of biosimilars in oncology and ways in which the anticipated cost-savings may be achieved.
Winston Wong, PharmD, breaks down the ASCO position statement on the utilization of biosimilars in oncology and ways in which the anticipated cost-savings may be achieved.
Winston Wong, PharmD, breaks...
09/12/2018
Journal of Clinical Pathways
Editor Insights
Next-Generation Clinical Pathways
07/20/2018

Winston Wong, PharmD

Winston Wong, PharmD
Winston Wong, PharmD, highlights the relevance of personalized medicine in oncology care and outlines his views on what the "next-generation clinical pathway" should look like.
Winston Wong, PharmD, highlights the relevance of personalized medicine in oncology care and outlines his views on what the "next-generation clinical pathway" should look like.
Winston Wong, PharmD, highlights...
07/20/2018
Journal of Clinical Pathways
Editor Insights
Value-Based Oncology Care: It's All in the Eye of the Beholder
06/07/2018

Winston Wong, PharmD

Winston Wong, PharmD
As with so many other key words in health care today, there is no standard definition of what “value-based oncology care” entails; it is subject to different interpretations from payers, providers, and patients, according to Winston Wong,...
As with so many other key words in health care today, there is no standard definition of what “value-based oncology care” entails; it is subject to different interpretations from payers, providers, and patients, according to Winston Wong,...
As with so many other key words...
06/07/2018
Journal of Clinical Pathways

Data Science for HCPs

The Guardrails of Data Science: Regulations and Certifications for Health Care
Data Science for HCPs
The Guardrails of Data Science: Regulations and Certifications for Health Care
01/20/2021
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael...
01/20/2021
Journal of Clinical Pathways
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
Data Science for HCPs
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
06/25/2020
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and...
06/25/2020
Journal of Clinical Pathways
Extraction, Transformation, and Loading: The ETL of Data Engineering
Data Science for HCPs
Extraction, Transformation, and Loading: The ETL of Data Engineering
05/18/2020
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and...
05/18/2020
Journal of Clinical Pathways
Data Science for HCPs
Data Engineering: The Foundation of Data Science Efforts
04/09/2020

David Hughes, BSN; Victor M Gehman, PhD; Michael Becich, MS; Amal Katrib, PhD; David Whewell; Erwan Rivet, MBA, MSME; Kelly Leyden MRes; Anisha Keshavan, PhD; Fatima Rubio da Costa, PhD

David Hughes, BSN; Victor M Gehman, P...
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and...
04/09/2020
Journal of Clinical Pathways
Data Science for HCPs
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
03/14/2020

Victor Gehman, PhD; Michael Becich, MS; Amal Katrib, PhD; Fatima Rubio da Costa, PhD; David Whewell; David Hughes, BSN

Victor Gehman, PhD; Michael Becich, M...
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and...
03/14/2020
Journal of Clinical Pathways
Data Science for HCPs
Introduction to Data Science for Health Care Professionals
02/11/2020

David Hughes, BSN—Blog Editor; Michael Becich, MS; Victor Gehman, PhD; Anisha Keshavan, PhD; Amal Katrib, PhD; Kelly Leyden, MRes; Fatima Rubio da Costa, PhD; Melinda Thomas; Michael Towbin; David Whewell

David Hughes, BSN—Blog Editor; Michae...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the...
02/11/2020
Journal of Clinical Pathways
The Guardrails of Data Science: Regulations and Certifications for Health Care
Data Science for HCPs
The Guardrails of Data Science: Regulations and Certifications for Health Care
01/20/2021
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael...
01/20/2021
Journal of Clinical Pathways
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
Data Science for HCPs
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
06/25/2020
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and...
06/25/2020
Journal of Clinical Pathways
Extraction, Transformation, and Loading: The ETL of Data Engineering
Data Science for HCPs
Extraction, Transformation, and Loading: The ETL of Data Engineering
05/18/2020
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and...
05/18/2020
Journal of Clinical Pathways
Data Science for HCPs
Data Engineering: The Foundation of Data Science Efforts
04/09/2020

David Hughes, BSN; Victor M Gehman, PhD; Michael Becich, MS; Amal Katrib, PhD; David Whewell; Erwan Rivet, MBA, MSME; Kelly Leyden MRes; Anisha Keshavan, PhD; Fatima Rubio da Costa, PhD

David Hughes, BSN; Victor M Gehman, P...
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and...
04/09/2020
Journal of Clinical Pathways
Data Science for HCPs
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
03/14/2020

Victor Gehman, PhD; Michael Becich, MS; Amal Katrib, PhD; Fatima Rubio da Costa, PhD; David Whewell; David Hughes, BSN

Victor Gehman, PhD; Michael Becich, M...
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and...
03/14/2020
Journal of Clinical Pathways
Data Science for HCPs
Introduction to Data Science for Health Care Professionals
02/11/2020

David Hughes, BSN—Blog Editor; Michael Becich, MS; Victor Gehman, PhD; Anisha Keshavan, PhD; Amal Katrib, PhD; Kelly Leyden, MRes; Fatima Rubio da Costa, PhD; Melinda Thomas; Michael Towbin; David Whewell

David Hughes, BSN—Blog Editor; Michae...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the...
02/11/2020
Journal of Clinical Pathways

Healthcare Economist

Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Distributional Cost-Effectiveness Analysis: A Simple Example
02/09/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6...
02/09/2022
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Alternative Payment Models: Where Are We Now?
02/07/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a...
02/07/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Impact of Biosimilar Entry on Drug Costs
12/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Which Strategies Are Payers and Employers Using to Cover Ophan Drugs?
06/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
Healthcare Economist
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
10/09/2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights...
10/09/2020
Journal of Clinical Pathways
The Need for Continuous Cost-Effectiveness Analysis
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Are Value-Based Agreements the Solution to High Drug Prices?
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Distributional Cost-Effectiveness Analysis: A Simple Example
02/09/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6...
02/09/2022
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Alternative Payment Models: Where Are We Now?
02/07/2022

Jason Shafrin, PhD

Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a...
02/07/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Impact of Biosimilar Entry on Drug Costs
12/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Which Strategies Are Payers and Employers Using to Cover Ophan Drugs?
06/20/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
Healthcare Economist
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
10/09/2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights...
10/09/2020
Journal of Clinical Pathways
The Need for Continuous Cost-Effectiveness Analysis
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Are Value-Based Agreements the Solution to High Drug Prices?
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways

Quality Outlook

Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024

Kendall Logan, MPH; Anne DiSalvo, MPH, MBA; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Kendall Logan, MPH; Anne DiSalvo, MPH...
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024

Theresa Schmidt, MA; Danny Bellet, MBA; Donna Dugan, PhD, MS; Erik Muther; David Sloan, PhD; Tom Valuck, MD, JD

Theresa Schmidt, MA; Danny Bellet, MB...
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023

David Blaisdell; Blog Editor: Tom Valuck, MD, JD

David Blaisdell; Blog Editor: Tom Val...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023

Jacqlyn Riposo, MBA; Tom Valuck, MD, JD

Jacqlyn Riposo, MBA; Tom Valuck, MD, ...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023

David Blaisdell; Sarena Ho, MSPH; Tom Valuck, MD, JD

David Blaisdell; Sarena Ho, MSPH; Tom...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022

Nina Regenold, MSc; Kaitlyn Esselman, MHS; David Blaisdell; Eva Lenoir, MPH; and Tom Valuck, MD, JD

Nina Regenold, MSc; Kaitlyn Esselman,...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways
Jan Ileto, MSPH
Quality Outlook
Turning Down the Heat: Measuring the Effects of Climate Change to Improve Health Equity
04/26/2022

Jan Ileto, MSPH, Jacqlyn Riposo, MBA, Alexis Malfesi, MSHS; Blog Editor: Tom Valuck, MD, JD 

Jan Ileto, MSPH, Jacqlyn Riposo, MBA,...
This blog explores the intersection between climate change and health equity, discussing opportunities to leverage quality measurement and value-based payment incentives to drive climate action and mitigate impacts on health equity.
This blog explores the intersection between climate change and health equity, discussing opportunities to leverage quality measurement and value-based payment incentives to drive climate action and mitigate impacts on health equity.
This blog explores the...
04/26/2022
Journal of Clinical Pathways
Rachael Peroutky, MSPH
Quality Outlook
Nurses are Burned Out. Can Quality Measures Help?
04/11/2022

Rachael Peroutky, MSPH, Tess Donckels, MSPH, Sarena Ho, Katie Schultz, Sara Khan Shirsekar; Blog Editor: Tom Valuck, MD, JD 

Rachael Peroutky, MSPH, Tess Donckels...
This blog addresses "nurse burnout," the occupational phenomena that many nurses face, and suggests that quality measurement strategies for nurse burnout may be most effective in the hospital setting since evidence tying burnout to patient...
This blog addresses "nurse burnout," the occupational phenomena that many nurses face, and suggests that quality measurement strategies for nurse burnout may be most effective in the hospital setting since evidence tying burnout to patient...
This blog addresses "nurse...
04/11/2022
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
Veronica Ellis
Sara Valek, MPH
Kaitlyn Esselman, MHS
Tom Valuck, MD, JD—Blog Editor
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024

Kendall Logan, MPH; Anne DiSalvo, MPH, MBA; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Kendall Logan, MPH; Anne DiSalvo, MPH...
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024

Theresa Schmidt, MA; Danny Bellet, MBA; Donna Dugan, PhD, MS; Erik Muther; David Sloan, PhD; Tom Valuck, MD, JD

Theresa Schmidt, MA; Danny Bellet, MB...
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023

David Blaisdell; Blog Editor: Tom Valuck, MD, JD

David Blaisdell; Blog Editor: Tom Val...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023

Jacqlyn Riposo, MBA; Tom Valuck, MD, JD

Jacqlyn Riposo, MBA; Tom Valuck, MD, ...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023

David Blaisdell; Sarena Ho, MSPH; Tom Valuck, MD, JD

David Blaisdell; Sarena Ho, MSPH; Tom...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022

Nina Regenold, MSc; Kaitlyn Esselman, MHS; David Blaisdell; Eva Lenoir, MPH; and Tom Valuck, MD, JD

Nina Regenold, MSc; Kaitlyn Esselman,...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways
Jan Ileto, MSPH
Quality Outlook
Turning Down the Heat: Measuring the Effects of Climate Change to Improve Health Equity
04/26/2022

Jan Ileto, MSPH, Jacqlyn Riposo, MBA, Alexis Malfesi, MSHS; Blog Editor: Tom Valuck, MD, JD 

Jan Ileto, MSPH, Jacqlyn Riposo, MBA,...
This blog explores the intersection between climate change and health equity, discussing opportunities to leverage quality measurement and value-based payment incentives to drive climate action and mitigate impacts on health equity.
This blog explores the intersection between climate change and health equity, discussing opportunities to leverage quality measurement and value-based payment incentives to drive climate action and mitigate impacts on health equity.
This blog explores the...
04/26/2022
Journal of Clinical Pathways

Guest Blogs

Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD
David Gruber, MD, MBA
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
Guest Blog
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
How Digital Solutions Help Drive Patient-Focused Health Care
Guest Blog
How Digital Solutions Help Drive Patient-Focused Health Care
02/18/2021

Leo P Langlois, MD, PT

Leo P Langlois, MD, PT
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
Adapting Pathways in a Pandemic
05/08/2020

Gordon Kuntz

Gordon Kuntz
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
Deprescribing: A Tool for Cost Reduction and Improved Outcomes?
07/11/2019

Marsha K. Millonig, MBA, BPharm

Marsha K. Millonig, MBA, BPharm ...
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
Achieving “Victory” Through Holistic Palliative Care
07/03/2019

Adil Akhtar, MD

Adil Akhtar, MD
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
Pharmacogenomics: Preemptive Testing Decisions Reach Across the Care Team
01/07/2019

Kandace Schuft, PharmD

Kandace Schuft, PharmD
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
Health Insurance Aside, Americans Still Struggle to Pay for Their Medications
12/14/2018

Thomas Goetz, MPH, RxPerts Academy

Thomas Goetz, MPH, RxPerts Academy ...
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
Potential Administrative Burdens in Oncology Clinical Pathways
05/07/2018

Sowmya Josyula, MD, MPH and Bobby Daly, MD, MBA

Sowmya Josyula, MD, MPH and Bobby Dal...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
Why Palliative Care is More Than Just Care for the Dying
04/28/2018

Tim Holder, MD

Tim Holder, MD
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways
Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD
David Gruber, MD, MBA
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
Guest Blog
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
How Digital Solutions Help Drive Patient-Focused Health Care
Guest Blog
How Digital Solutions Help Drive Patient-Focused Health Care
02/18/2021

Leo P Langlois, MD, PT

Leo P Langlois, MD, PT
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
Adapting Pathways in a Pandemic
05/08/2020

Gordon Kuntz

Gordon Kuntz
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
Deprescribing: A Tool for Cost Reduction and Improved Outcomes?
07/11/2019

Marsha K. Millonig, MBA, BPharm

Marsha K. Millonig, MBA, BPharm ...
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
Achieving “Victory” Through Holistic Palliative Care
07/03/2019

Adil Akhtar, MD

Adil Akhtar, MD
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
Pharmacogenomics: Preemptive Testing Decisions Reach Across the Care Team
01/07/2019

Kandace Schuft, PharmD

Kandace Schuft, PharmD
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
Health Insurance Aside, Americans Still Struggle to Pay for Their Medications
12/14/2018

Thomas Goetz, MPH, RxPerts Academy

Thomas Goetz, MPH, RxPerts Academy ...
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
Potential Administrative Burdens in Oncology Clinical Pathways
05/07/2018

Sowmya Josyula, MD, MPH and Bobby Daly, MD, MBA

Sowmya Josyula, MD, MPH and Bobby Dal...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
Why Palliative Care is More Than Just Care for the Dying
04/28/2018

Tim Holder, MD

Tim Holder, MD
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways

Payer Voice

Payer Voice
Creating Accountability to Patients: A Response to the Roundtable on Value-Based Agreements
08/06/2019
Lili Brillstein, MPH, responds to the recent roundtable discussion held at the ASCO Annual Meeting that explored value-based agreements for oncology care in the US.
Lili Brillstein, MPH, responds to the recent roundtable discussion held at the ASCO Annual Meeting that explored value-based agreements for oncology care in the US.
Lili Brillstein, MPH, responds...
08/06/2019
Journal of Clinical Pathways
Payer Voice
Creating Accountability to Patients: A Response to the Roundtable on Value-Based Agreements
08/06/2019
Lili Brillstein, MPH, responds to the recent roundtable discussion held at the ASCO Annual Meeting that explored value-based agreements for oncology care in the US.
Lili Brillstein, MPH, responds to the recent roundtable discussion held at the ASCO Annual Meeting that explored value-based agreements for oncology care in the US.
Lili Brillstein, MPH, responds...
08/06/2019
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP March/April 2024

Current Issue

April 2024
Volume 10
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement